• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在大量调节性 T 细胞抑制的情况下,通过 LIGHT 促进免疫反应。

Promoting immune responses by LIGHT in the face of abundant regulatory T cell inhibition.

机构信息

Department of Pathology, University of Chicago, Chicago, IL 60637, USA.

出版信息

J Immunol. 2010 Feb 1;184(3):1589-95. doi: 10.4049/jimmunol.0901582. Epub 2009 Dec 30.

DOI:10.4049/jimmunol.0901582
PMID:20042587
Abstract

CD4(+) regulatory T cell (Treg) populations are believed to play very important roles in the suppression of immune responses. Overriding Treg inhibition is necessary for initiating primary immune reaction upon inflammatory Ag stimulation. LIGHT, TNF superfamily member 14, has been shown to be a costimulatory molecule for effector T cells. Overexpression of lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpesvirus entry mediator on T cells (LIGHT) on T cells induces strong T cell-mediated experimental intestinal inflammation. How this process is initiated by LIGHT in suppressive intestinal environments remains incompletely understood. In this study, we assessed the effect of LIGHT on Tregs. Our results indicate that LIGHT can support the expansion and function of Tregs. However, when LIGHT was highly expressed, these abundant Tregs failed to suppress the development of T cell-mediated experimental colitis and antitumor immunity. We showed that this might be, in part, due to an ability of LIGHT to promote effector T cell proliferation and differentiation even in a Treg-abundant environment. Our data collectively suggest that LIGHT might be a critical cytokine involved in the development of autoimmune inflammatory diseases and that LIGHT-targeted immunotherapy might be useful in the treatment of these diseases.

摘要

CD4(+) 调节性 T 细胞(Treg)群体被认为在抑制免疫反应方面发挥着非常重要的作用。在炎症抗原刺激时,需要克服 Treg 的抑制作用,以启动初始免疫反应。LIGHT,肿瘤坏死因子超家族成员 14,已被证明是效应 T 细胞的共刺激分子。在 T 细胞上过度表达与疱疹病毒进入介体竞争结合糖蛋白 D 的淋巴毒素相关诱导配体(LIGHT)可诱导强烈的 T 细胞介导的实验性肠道炎症。LIGHT 在抑制性肠道环境中如何启动这一过程尚不完全清楚。在这项研究中,我们评估了 LIGHT 对 Treg 的影响。我们的结果表明,LIGHT 可以支持 Treg 的扩增和功能。然而,当 LIGHT 高表达时,这些丰富的 Treg 未能抑制 T 细胞介导的实验性结肠炎和抗肿瘤免疫的发展。我们表明,这可能部分是由于 LIGHT 能够促进效应 T 细胞的增殖和分化,即使在 Treg 丰富的环境中也是如此。我们的数据表明,LIGHT 可能是参与自身免疫性炎症性疾病发展的关键细胞因子,LIGHT 靶向免疫疗法可能对这些疾病的治疗有用。

相似文献

1
Promoting immune responses by LIGHT in the face of abundant regulatory T cell inhibition.在大量调节性 T 细胞抑制的情况下,通过 LIGHT 促进免疫反应。
J Immunol. 2010 Feb 1;184(3):1589-95. doi: 10.4049/jimmunol.0901582. Epub 2009 Dec 30.
2
Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.Smad7控制致结肠炎T细胞对调节性T细胞介导抑制的抗性。
Gastroenterology. 2009 Apr;136(4):1308-16, e1-3. doi: 10.1053/j.gastro.2008.12.053. Epub 2008 Dec 27.
3
The tumor necrosis factor family member TNFSF14 (LIGHT) is required for resolution of intestinal inflammation in mice.肿瘤坏死因子家族成员 TNFSF14(LIGHT)是小鼠肠道炎症消退所必需的。
Gastroenterology. 2014 Jun;146(7):1752-62.e4. doi: 10.1053/j.gastro.2014.02.010. Epub 2014 Feb 19.
4
TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.TNFR2 在炎症环境中对于 CD4+Foxp3+调节性 T 细胞表型的稳定至关重要。
J Immunol. 2013 Feb 1;190(3):1076-84. doi: 10.4049/jimmunol.1202659. Epub 2012 Dec 31.
5
Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.在结肠炎恢复过程中,Foxp3+调节性T细胞通过Fas/Fas配体诱导的死亡发生短暂局部耗竭。
J Immunol. 2008 Jun 15;180(12):8316-26. doi: 10.4049/jimmunol.180.12.8316.
6
CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis.CD8+CD122+ 调节性 T 细胞(Tregs)和 CD4+Tregs 协同预防和治疗 CD4+细胞诱导的结肠炎。
J Immunol. 2011 Jan 1;186(1):41-52. doi: 10.4049/jimmunol.1000800. Epub 2010 Nov 22.
7
The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease.LIGHT在促进肠道炎症和克罗恩病中的关键作用。
J Immunol. 2005 Jun 15;174(12):8173-82. doi: 10.4049/jimmunol.174.12.8173.
8
Regulatory T cells restrain CD4+ T cells from causing unregulated immune activation and hypersensitivity to lipopolysaccharide challenge.调节性T细胞抑制CD4 + T细胞引起不受控制的免疫激活和对脂多糖攻击的超敏反应。
J Immunol. 2014 Jul 15;193(2):655-62. doi: 10.4049/jimmunol.1303064. Epub 2014 Jun 18.
9
Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells.调节性CD4+CD25+Foxp3+ T细胞选择性抑制淋巴细胞减少诱导的幼稚T细胞自发增殖形式。
J Immunol. 2008 Jun 1;180(11):7305-17. doi: 10.4049/jimmunol.180.11.7305.
10
CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.CD4+CD25+调节性T细胞需要细胞毒性T淋巴细胞相关抗原4(CTLA-4)来控制CD4+ T细胞淋巴细胞减少诱导的增殖。
Eur J Immunol. 2009 Jun;39(6):1544-51. doi: 10.1002/eji.200838603.

引用本文的文献

1
ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in glioma.锌指蛋白503反义RNA2(ZNF503-AS2)是一个很有前景的治疗靶点,且与胶质瘤中的免疫微环境相关。
PLoS One. 2024 Dec 2;19(12):e0314618. doi: 10.1371/journal.pone.0314618. eCollection 2024.
2
Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas.全面表征 TNFSF14/LIGHT 在人类神经胶质瘤预后和免疫治疗中的作用。
Front Immunol. 2022 Oct 20;13:1025286. doi: 10.3389/fimmu.2022.1025286. eCollection 2022.
3
Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy.
用于炎症的生物传感器作为用于细胞治疗的调节性 T 细胞工程的策略。
Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2208436119. doi: 10.1073/pnas.2208436119. Epub 2022 Sep 26.
4
Realigning the LIGHT signaling network to control dysregulated inflammation.调整 LIGHT 信号通路网络以控制失调的炎症反应。
J Exp Med. 2022 Jul 4;219(7). doi: 10.1084/jem.20220236. Epub 2022 May 23.
5
Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries.脓毒症诱导多器官损伤中循环LIGHT(肿瘤坏死因子超家族成员14)和白细胞介素-18水平
Biomedicines. 2022 Jan 25;10(2):264. doi: 10.3390/biomedicines10020264.
6
Pre-transplant Transcriptional Signature in Peripheral Blood Mononuclear Cells of Acute Renal Allograft Rejection.急性肾移植排斥反应外周血单个核细胞中的移植前转录特征
Front Med (Lausanne). 2022 Jan 7;8:799051. doi: 10.3389/fmed.2021.799051. eCollection 2021.
7
A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.基于免疫基因组分析的胶质母细胞瘤新型 Foxp3 相关免疫预后标志物。
Aging (Albany NY). 2021 Jan 10;13(3):3501-3517. doi: 10.18632/aging.202282.
8
TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy.TNFSF14:为有效的癌症免疫疗法指明道路。
Front Immunol. 2020 May 15;11:922. doi: 10.3389/fimmu.2020.00922. eCollection 2020.
9
Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.在实验性自身免疫性脑脊髓炎的口服干预后,调节性T细胞功能障碍会默认BTLA +调节性B细胞。
J Immunol. 2016 Jun 15;196(12):5036-46. doi: 10.4049/jimmunol.1501973. Epub 2016 May 18.
10
Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.《抗体工程与治疗学》,抗体协会2015年12月7日至10日在美国加利福尼亚州圣地亚哥举行的年会。
MAbs. 2016;8(3):617-52. doi: 10.1080/19420862.2016.1153211.